Precise editing of the human germline has been considered an unlikely and an unethical proposition. Recently, tools to edit the human germline have been developed and it is now a realistic prospect. Consequently, the ethical arguments around prohibiting human genome editing need to be re-evaluated. It is anticipatable that using it to eradicate disease-causing mutations will be acceptable if clinical risks can be shown to be sufficiently low. Some go further and advocate that genetically ‘enhancing’ humans will also be permissible. Here I argue that there are instances where human germline editing should be prohibited because harms can be anticipated from the results of studies of aspects of human psychology. The example I have chosen to illustrate this argument is prolongation of the human lifespan. Cohort and longitudinal studies demonstrate that a vital ingredient of human contentment and health is being integrated into a cohort of similarly aged people and experiencing life's trials and tribulations contemporaneously. A person genetically engineered to live longer than their peers will experience the loss of their cohort and many from the generation following them—an established risk factor for discontentment and ill health. Since germline genome editing precludes obtaining the consent of the individual in question, and that such a predictable harm will be commonly encountered, it is questionable that human germline editing to extend lifespan can ever be considered an ethical practice.
- Genetic Engineering
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Is it better to die than to be lonely?
- Moral reasons to edit the human genome: picking up from the Nuffield report
- CRISPR-Cas9: a new and promising player in gene therapy
- Sport and exercise genomics: the FIMS 2019 consensus statement update
- Ethics of modifying the mitochondrial genome
- Experts back genome editing in human embryo research
- Heritable human genome editing is ‘currently not permitted’, but it is no longer ‘prohibited’: so says the ISSCR
- CRISPR immunity: a case study for justified somatic genetic modification?
- The ‘serious’ factor in germline modification
- Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR